Human immunodeficiency virus type 1 activation after blood transfusion

Transfusion

Volumn 36, Issue 10, 1996, Pages 860-865

  Mudido, P M ^a,b,c,d   Georges, D ^a   Dorazio, D ^a   Yen Lieberman, B ^a   Bae, S ^a   O'Brien, W A ^a   Spritzler, J ^a   Lederman, M M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; INTERLEUKIN 2; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; VIRUS ACTIVATION; VIRUS EXPRESSION;

EID: 0029797159     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.361097017170.x     Document Type: Article

References (25)

1. Wenger JD, Whalen CC, Lederman MM, et al. Prognostic factors in acquired immune deficiency syndrome. J Gen Intern Med 1988;3:464-70.
2. Sathe SS, Gascone P, Lo W, et al. Severe anemia is an important negative predictor for survival with disseminatedMycobacteriwn avium-intracellulare in acquired immunodeficiency syndrome. AmRevRespDis 1990;142:1306-12.
3. Chaisson RE, Moore RD, Richman DD, et al. Incidence and natural history ofMycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. Am Rev Resp Dis 1992;146:285-9.
4. Vamvakas E, Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 1993;33:111-8.
5. Chin DP, Reingold AL, Stone EN, et al. The impact of Mycobacterium avlum complex bacteremia and its treatment on survival of AIDS patients-a prospective study. J Infect Dis 1994;170:578-84.
6. Busch M, Lee TH, Heitman J. Allogenic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood 1992:80:2128-35.
7. Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion 1990;30:651-8.
8. Gascon P, Zoumbos NC, Young NS. Immunological abnormalities in patients receiving multiple blood transfusions. Ann Intern Med 1984:100:173-7.
9. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984:64:308-10.
10. Urdea M. Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV, and HIV. Clin Chem 1993:39:725-6.
11. Urdea MS, Wilber JC, Yeghiazarian T, et al. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 1993;7:S11-4.
12. Gibbons JD. Permutation tests. In: Kotz S, Johnson NL, eds. Encyclopedia of statistical sciences, vol 6. New York: John Wiley & Sons, 1985:690.
13. O'Brien\VA,Grovit-FerbasK,NamaziA,etal.HIV-l replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
14. Riddler SA, Holodniy M, White RA, et al. Diurnal and within patient variation of HIV viral load (abstract 256). Presented at the Third Conference on Retroviruses and Opportunistic Infections, Infectious Diseases Society of America, Washington, DC, January 28-February 1, 1996.
15. Schlechter GP, Soehnlen F, McFarland W. Lymphocyte response to blood transfusion in man. N Engl J Med 1972;287:1169-73.
16. Butcher EC. The regulation of lymphocyte traffic. Curr Top Microbiol Immunol 1986;128:85-122.
17. Smith KJ, Sierra ER, Nelson EJ. Histamine, IL-I, and IL-8 increase in packed RBCs stored for 42 days but not in RBCs leukodepleted pre-storage (abstract). Transfusion 1993;33:53S.
18. Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor a (TNFa), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFa and IL-6 levels and febrile transfusion reactions. Transfusion 1993:33:195-9.
19. Vyakarnam A, McKeating J, Meager A, Beverley PC. Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 1990:4:21-7.
20. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-8.
21. Davis MG, Kenny SC, Kamine J, et al. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sei USA 1987:84:8642-6.
22. Kovacs JA, Baseler M, Dewar RJ, et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med 1995:332:567-75.
23. Mole L, Ripich S, Margolis D, et al. Plasma HIV RNA levels are increased during'active Herpes simplex virus infection. In: Program and abstracts of the 2nd National Conference on Human Retroviruses, American Society for Microbiology in collaboration with the NIH and CDC, Washington DC. 1995:#239.
24. Brichacek B, Swindells S, Janoff E, Stevenson M. Immune activation and control of viral burden in AIDS. In: Program and abstracts of the 2nd National Conference on Human Retroviruses, American Society for Microbiology, Washington, DC, 1995:#240.
25. Chapman L, Hartley M, Khan A, Guenthner P, et al. Changes in plasma HIV RNA after immune activation by vaccinations and acute illnesses. In: Program and abstracts of the 2nd National Conference on Human Retroviruses. American Society for Microbiology, Washington, DC, 1995:#241.